Puerto Rico set to achieve life science export potential
Air trade demand from Puerto Rico (PR) to mainland US reflects its growing life science ...
© Khunaspix Dreamstime.
By Alex Lennane
The vast amounts of investment and research that logistics companies are putting into the pharmaceutical shipment business could soon be at least partly defunct following the first approval of 3D-printed drugs. Developed by Aprecia, the approved drug is to help control epilepsy and the 3D print process allows for a new, easy-to-dissolve structure as well as individual dosage control. This allows personalised medicine to be easily manufactured, delivered and stored. Will all that pharma cold chain expertise be wasted? Time will tell.
Comment on this article